Skip to main content
. 2024 Aug 23;12(8):E989–E995. doi: 10.1055/a-2375-7568

Table 1 Overview of FTRD interventions with subdivision according to indication.

Overall
(n = 91)		 Non-lifting adenoma
(n = 65)		 SET
(n = 18)		 Carcinoma
(n = 8)
eFTR, endoscopic full-thickness resection; FTRD, full-thickness resection device; FU, follow-up; RRL, recurrent/residual lesion; SD, standard deviation; SET, subepithelial tumor.
Age years (SD) 63 (12) 67 (12) 53 (12) 62 (12)
Sex, n (%)

  • Female

 36 (40) 25 (38) 9 (50) 2 (25)

  • Male

 55 (60) 40 (62) 9 (50) 6 (75)
Localization, n (%)

  • Cecum

 15 (16) 13 (20) 1 (5.6) 1 (12.5)

  • Ascending colon

 19 (21) 18 (27.7) 0 1 (12.5)

  • Transverse colon

 12 (13) 8 (12.3) 3 (16.6) 1 (12.5)

  • Descending colon

 4 (4) 4 (6.1) 0 0

  • Sigmoid colon

 15 (16) 12 (18.5) 2 (11.1) 1 (12.5)

  • Rectum

 26 (29) 10 (15.4) 12 (66.7) 4 (50)
Initial lesion size (average, SD mm) 21 (8–60) 22 (8–60) 20 (9–26) 24 (8–33)
Initial lesion size pure eFTR 21 (8–35) 21 (8–35) 20 (9–26) 24 (8–33)
Initial lesion size hybrid eFTR 28 (20–60) 28 (20–60) – –
Hybrid EFTR, n (%) 8 (8.8) 8 (12.3) 0 0
Full-thickness resection, n (%) 74 (81.3) 53 (81.5) 16 (88.9) 5 (62.5)
R0 resection, n (%) 80 (87.9) 54 (83.1) 18 (100) 8 (100)
Follow-up 0 0

  • RRL, n (%)

9 (9.9) 9 (13.8)
  without hybrid eFTR 6 (7.2) 6 (10,5)

  • Median FU till RRL, months (min-max)

 15.5 (2–50) 15.5 (2–50) – –

  • Total number follow-up, median (range)

 2 (1–6) 2 (1–5) 2 (1–6) 2 (1–4)

  • First follow-up, months (min-max)

 4.3 (1–57) 4.3 (2–46) 4.2 (1–57) 3.9 (2–42)

  • Last follow-up, months (min-max)

 16.8 (2–86) 16.7 (2–83) 16.8 (3–86) 19.5 (4–42)

  • Clip (in situ vs. ex), n (%)

 15 (17) vs. 76 (83) 11 (17) vs. 54 (83) 4 (22) vs. 14 (78) 0 vs. 8 (100)